TCTR20170228002Enrolling By Invitation3 期
The safety and efficacy of plasma-derived factor VIII concentrate produced by National Blood Center, Thai Red Cross Society
Thai Hematology Society0 个研究点目标入组 50 人开始时间: 2017年2月28日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10 Years 至 60 Years（—）
- 性别
- Male
入选标准
- •Hemophilia A patient, age equal to or more than ten years of age.
排除标准
- •Hemophilia A patients with inhibitor.
研究者
相似试验
招募中
Unknown
Comparing the safety and effectiveness of plasma rich fibrin (PRF) to plasma rich platelet (PRP) in the treatment of periorbital rejuvenation and hyperpigmentatioDark circles and wrinkles under the eyes.Chloasma of eyelid and periocular areaH02.71IRCT20200127046282N51Tehran University of Medical Sciences25
招募中
不适用
Efficacy and Safety Evaluation According to Plasma Concentration Measurement on Direct Oral Anticoagulation Using Factor-Xa Inhibitors for Non-valvular Atrial Fibrillation on Multicenter Studyon-valvular atrial fibrillationJPRN-UMIN000036769Hokusetsu General Hospital Clinical laboratory division3,000
已完成
2 期
Efficacy and safety of platelet-rich plasma (PRP) in the treatment of male pattern hair lossandrogenic alopecia.Androgenic alopecia Incl.: male-pattern baldnessIRCT2014110919870N1Mehrashkar company
招募中
不适用
Effectiveness and Safety of Platelet-Rich Plasma Injection for Achilles Tendon Rupture RepairAchilles tendon ruptureJPRN-UMIN000036496Teikyo University14
尚未招募
3 期
Efficacy and Safety of Platelet Rich Plasma in Burn patients with granulating WoundsCTRI/2024/05/068042ICMR